Edgewise Therapeutics
Ryan Waite is an accomplished professional in the field of business development, currently serving as the Head of Business Development at Edgewise Therapeutics since April 2024. Prior to this role, Ryan was the Senior Director of Business Development at Coherus BioSciences from September 2019 to April 2024, focusing on business development, licensing, and contract negotiation. Previous experience includes positions such as Associate Director of Market Planning at Clovis Oncology, Business Consultant at ZS Associates, and Senior Consultant at Simon-Kucher & Partners, all with a concentration on business development and licensing. Ryan Waite holds an MBA from the University of Michigan - Stephen M. Ross School of Business and a Bachelor of Science in Biochemistry and Molecular Biology from the University of California, Davis.
This person is not in any teams
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.